聯想集團年報:現金流造血能力強勁,財務健康邊際牢固
格隆匯5月24日丨聯想集團公佈截至2023年4月30日的2022/23財年全年及第四財季業績:全年營收為4240億人民幣,淨利潤129億人民幣。聯想集團董事長兼CEO楊元慶表示,聯想的運營狀況保持健康,現金儲備和現金循環週期都得到進一步改善。數據顯示,憑藉着多元化增長引擎和卓越的運營能力,聯想集團全年淨現金狀況保持穩健,年末結餘為3.66億美元,表現超出市場預期。同時,公司籌資活動和投資活動產生的現金淨流出遠少於經營活動產生的現金淨流入,現金流強勁;在營運資金管理方面,聯想集團的現金週期縮短至負2天,同比改善了12天,表明其主營業務實際現金流造血能力遠高於其利潤表賬面的綜合盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.